From May 1 to May 6, the European Congress of Physical and Rehabilitation Medicine (ESPRM 2020) will be held in Belgrade. As part of this event, several presentations will be made on innovative development of Parapharm Company – dietary supplement «Osteomed Forte».
ESPRM 2020 – a platform for discussing the most pressing issues
ESPRM Congress 2020 is held for the 22th time. For such a long time the Congress went beyond the scope of an exclusively European event. This year, for instance, honored guests from Israel, USA and Canada are expected here. Leading experts in the field of rehabilitative medicine from Serbia, Russia, Ukraine, Switzerland, Italy, Spain, Bulgaria, Greece and several other European countries will also take part in the Congress.
Among the delegates from our country, this event will be attended by Candidate of Medical Sciences, Member of World Society of Physical and Rehabilitation Medicine and European Society of Endocrinology Larisa Aleksandrovna Marchenkova. A key area of scientific work of Dr. Marchenkova for over than 20 years is the problem of osteoporosis. Today Larisa A. Marcjenkova directs a center for rehabilitation of patients with osteoporosis in Moscow.
The diseases of the musculoskeletal system are always in the focus of the Congress. Therefore, the report of Dr. Marchenkova promises to be one of the central at the ESPRM Congress 2020.
«Osteomed Forte» – innovative solution of the problem of osteoporosis
Three reports of Dr. Marchenkova regarding osteoporosis will be heard at the upcoming ESPRM Congress 2020. The first is them focuses on the nutritional correction for bone disorders. The other two will address the effects of calcium, vitamin D3 and B6 supplements on patients with osteoporosis.
As an example of a truly affective medicine for combination therapy of bone pathologies, Larisa Marchenkova indicated «Osteomed Forte». This innovative osteoprotector will be discussed in each of the three reports. Dr. Marchenkova, who conducted preclinical trials of this supplement, managed to personally verify its effectiveness.
In particular, the researcher established an increase in muscle strength and maintaining bone homeostasis as a result of the course administration of «Osteomed Forte». It should be noted that the trials involved patients, including those with severe forms of osteoporosis. And in each case, a positive dynamics was identified.
«Osteomed Forte» will be presented at the European Congress ESPRM 2020. day 3
«Osteomed Forte» will be presented at the European Congress ESPRM 2020. day 4
